| | | |  | | | | By Elaine Chen Patrick Sison/AP The weight-loss effects of a new type of diabetes drug is causing rippling shortages, along with debate over who deserves access. Read More | | By Jason Mast Courtesy Charité A line of drugs that has transformed one deadly rare disease could moonlight as a treatment for a far more common one, pneumonia. Read More | | By Andrew Joseph Eric Gay/AP Infectious disease fellowship programs are scrambling after 44% didn't fill their slots during the annual "match." Is the pandemic to blame? Read More | | Sponsored Insight by PHARMACYCLICS & JANSSEN ONCOLOGY 'No one will advocate for me better than myself': Hannah's story of living with CLL Hannah was leading an active lifestyle as a full-time employee, foster parent of six, wife and enthusiastic crafter when she received her diagnosis of chronic lymphocytic leukemia (CLL), an incurable form of blood cancer. After about a year of treatment, it became clear Hannah needed a second opinion to get back to her lifestyle. Read more about Hannah's journey and why she chose to advocate for herself. | | By Ed Silverman The FDA inspected Valisure facilities after a stretch in which the company openly pushed the agency to do more to test drugs for impurities. Read More | | By Sanjula Jain Adobe Primary care visits are down 10.3% across U.S. cities relative to pre-pandemic levels. That means a health crisis is in the offing. Read More | | By John Wilkerson Milken Institute FDA Commissioner Robert Califf said the food side of the agency needs more attention Wednesday at a Milken Institute conference. Read More | | By Jayne Williamson-Lee STAT Advances in cancer treatments and screenings are outpacing the medical community's ability to assess them, says oncologist Otis Brawley. Read More | | By Damian Garde Adobe An investigative medicine from Prometheus Biosciences met its goals in a pair of Phase 2 studies for patients with inflammatory bowel disease. Read More | |
No comments